Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

American Thoracic Society 2019 Pediatric Core Curriculum.

Moore PE, Boyer D, Perkins R, Katz ES, Castro-Codesal ML, MacLean JE, Akil N, Esther CR Jr, Kaslow J, Lewis TC, Krone KA, Quizon A, Simpson R, Benscoter D, Spielberg DR, Melicoff E, Kuklinski CA, Blatter JA, Dy J, Rettig JS, Horani A, Gross J.

Pediatr Pulmonol. 2019 Dec;54(12):1880-1894. doi: 10.1002/ppul.24482. Epub 2019 Aug 27. Review.

PMID:
31456278
2.

Clinico-radiologic features of pleuroparenchymal fibroelastosis in children.

Nguyen HN, Das S, Gazzaneo MC, Melicoff E, Mallory GB, Eldin KW, Guillerman RP.

Pediatr Radiol. 2019 Aug;49(9):1163-1170. doi: 10.1007/s00247-019-04405-5. Epub 2019 Apr 19.

PMID:
31004186
3.

Risk factors for infection after pediatric lung transplantation.

Onyearugbulem C, Williams L, Zhu H, Gazzaneo MC, Melicoff E, Das S, Coss-Bu J, Lam F, Mallory G, Munoz FM.

Transpl Infect Dis. 2018 Dec;20(6):e13000. doi: 10.1111/tid.13000. Epub 2018 Oct 5.

PMID:
30221817
4.

Anellovirus loads are associated with outcomes in pediatric lung transplantation.

Blatter JA, Sweet SC, Conrad C, Danziger-Isakov LA, Faro A, Goldfarb SB, Hayes D Jr, Melicoff E, Schecter M, Storch G, Visner GA, Williams NM, Wang D.

Pediatr Transplant. 2018 Feb;22(1). doi: 10.1111/petr.13069. Epub 2017 Oct 29.

5.

Risk and outcomes of pulmonary fungal infection after pediatric lung transplantation.

Ammerman E, Sweet SC, Fenchel M, Storch GA, Conrad C, Hayes D Jr, Faro A, Goldfarb S, Melicoff E, Schecter M, Visner G, Williams NM, Danziger-Isakov L.

Clin Transplant. 2017 Nov;31(11). doi: 10.1111/ctr.13100. Epub 2017 Sep 18.

6.

Waiting list outcomes in pediatric lung transplantation: Poor results for children listed in adult transplant programs.

Scully BB, Goss M, Liu H, Keuht ML, Adachi I, McKenzie ED, Fraser CD, Melicoff E, Mallory GB, Heinle JS, Rana A.

J Heart Lung Transplant. 2017 Nov;36(11):1201-1208. doi: 10.1016/j.healun.2017.04.010. Epub 2017 Apr 24.

PMID:
28579113
7.

Bronchial artery revascularization and en bloc lung transplant in children.

Guzman-Pruneda FA, Orr Y, Trost JG, Zhang W, Das S, Melicoff E, Maddox J, Nugent M, Mery CM, Adachi I, Schecter MG, Mallory GB, Morales DL, Heinle JS, McKenzie ED.

J Heart Lung Transplant. 2016 Jan;35(1):122-9. doi: 10.1016/j.healun.2015.08.010. Epub 2015 Sep 3.

PMID:
26508727
8.

Altered Hypoxic-Adenosine Axis and Metabolism in Group III Pulmonary Hypertension.

Garcia-Morales LJ, Chen NY, Weng T, Luo F, Davies J, Philip K, Volcik KA, Melicoff E, Amione-Guerra J, Bunge RR, Bruckner BA, Loebe M, Eltzschig HK, Pandit LM, Blackburn MR, Karmouty-Quintana H.

Am J Respir Cell Mol Biol. 2016 Apr;54(4):574-83. doi: 10.1165/rcmb.2015-0145OC.

9.

Hypoxia-induced deoxycytidine kinase contributes to epithelial proliferation in pulmonary fibrosis.

Weng T, Poth JM, Karmouty-Quintana H, Garcia-Morales LJ, Melicoff E, Luo F, Chen NY, Evans CM, Bunge RR, Bruckner BA, Loebe M, Volcik KA, Eltzschig HK, Blackburn MR.

Am J Respir Crit Care Med. 2014 Dec 15;190(12):1402-12. doi: 10.1164/rccm.201404-0744OC.

10.

Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis.

Le TT, Karmouty-Quintana H, Melicoff E, Le TT, Weng T, Chen NY, Pedroza M, Zhou Y, Davies J, Philip K, Molina J, Luo F, George AT, Garcia-Morales LJ, Bunge RR, Bruckner BA, Loebe M, Seethamraju H, Agarwal SK, Blackburn MR.

J Immunol. 2014 Oct 1;193(7):3755-68. doi: 10.4049/jimmunol.1302470. Epub 2014 Aug 29.

11.

The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease.

Karmouty-Quintana H, Zhong H, Acero L, Weng T, Melicoff E, West JD, Hemnes A, Grenz A, Eltzschig HK, Blackwell TS, Xia Y, Johnston RA, Zeng D, Belardinelli L, Blackburn MR.

FASEB J. 2012 Jun;26(6):2546-57. doi: 10.1096/fj.11-200907. Epub 2012 Mar 13.

12.

Ca(2+) and calmodulin initiate all forms of endocytosis during depolarization at a nerve terminal.

Wu XS, McNeil BD, Xu J, Fan J, Xue L, Melicoff E, Adachi R, Bai L, Wu LG.

Nat Neurosci. 2009 Aug;12(8):1003-1010. doi: 10.1038/nn.2355. Epub 2009 Jul 26. Erratum in: Nat Neurosci. 2010 May;13(5):649. Dosage error in article text.

13.

Synaptotagmin-2 controls regulated exocytosis but not other secretory responses of mast cells.

Melicoff E, Sansores-Garcia L, Gomez A, Moreira DC, Datta P, Thakur P, Petrova Y, Siddiqi T, Murthy JN, Dickey BF, Heidelberger R, Adachi R.

J Biol Chem. 2009 Jul 17;284(29):19445-51. doi: 10.1074/jbc.M109.002550. Epub 2009 May 27.

14.

Compound vesicle fusion increases quantal size and potentiates synaptic transmission.

He L, Xue L, Xu J, McNeil BD, Bai L, Melicoff E, Adachi R, Wu LG.

Nature. 2009 May 7;459(7243):93-7. doi: 10.1038/nature07860.

15.

Synaptotagmin 2 couples mucin granule exocytosis to Ca2+ signaling from endoplasmic reticulum.

Tuvim MJ, Mospan AR, Burns KA, Chua M, Mohler PJ, Melicoff E, Adachi R, Ammar-Aouchiche Z, Davis CW, Dickey BF.

J Biol Chem. 2009 Apr 10;284(15):9781-7. doi: 10.1074/jbc.M807849200. Epub 2009 Feb 10.

16.

Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice.

Clement CG, Evans SE, Evans CM, Hawke D, Kobayashi R, Reynolds PR, Moghaddam SJ, Scott BL, Melicoff E, Adachi R, Dickey BF, Tuvim MJ.

Am J Respir Crit Care Med. 2008 Jun 15;177(12):1322-30. doi: 10.1164/rccm.200607-1038OC. Epub 2008 Apr 3.

17.

The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections.

Thakurdas SM, Melicoff E, Sansores-Garcia L, Moreira DC, Petrova Y, Stevens RL, Adachi R.

J Biol Chem. 2007 Jul 20;282(29):20809-15. Epub 2007 Apr 23.

18.

Synaptotagmin-2 is essential for survival and contributes to Ca2+ triggering of neurotransmitter release in central and neuromuscular synapses.

Pang ZP, Melicoff E, Padgett D, Liu Y, Teich AF, Dickey BF, Lin W, Adachi R, S├╝dhof TC.

J Neurosci. 2006 Dec 27;26(52):13493-504.

Supplemental Content

Loading ...
Support Center